Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Unbranded fictitious patient profiles following guidelines?
-
Hello PAAB, wondering if a fictitious, unbranded patient would need to follow guidelines in terms of their treatment journey? In real life, HCPs do not always follow guidelines.
i.e., if guidelines recommend Product X as first-line treatment, then Product Y as second-line treatment in refractory patients; could an unbranded patient profile show a patient being initiated on Product Y? Thank you! -
Hey @Username
No. Real or fictitious, a manufacturer should not be promoting patient treatment flows that are not reflective of guideline recommendations as per Code section 3.2.
